Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis

Fig. 5

Gut bacterial characteristics and main differences within the study groups during the intervention. a Differences (P < 0.05) in Tenericutes relative abundance after 3 months (T1), not considering the type of treatment. b Differences (P < 0.05) in Bacteroidetes relative abundance after 3 months (T1), not considering the type of treatment. c F/B ratio in the different time-treatment groups. d Differences (P < 0.05) in relative abundance of other families belonging to Bacteroidales within time, not considering the type of treatment. e Differences (P < 0.05) in Bacteroidaceae relative abundance within time, not considering the type of treatment. f Relative abundance of Bacteroidaceae in ALS patients considering the time and the type of treatment.g Differences (P = 0.05) in Rikenellaceae relative abundance in patients considering the time and the type of treatment. h Differences in α-diversity index observed OTU (P < 0.05) within time, not considering the type of treatment. i Differences in α-diversity index observed OTU (P < 0.05) considering the controls (C) and patients at T2 subgrouped in spinal (S) and bulbar (B) onset

Back to article page